DEVELOPMENT AND CHARACTERIZATION OF MEFENAMIC ACID EUTECTOGELS FOR CONTROLLED DRUG DELIVERY
ro (code pays fourni par la source)
1 citation
FARMACIA
Mihaela Nica
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
35Publications signalées
194Citations signalées
1Affiliations récentes
Les institutions déclarées
Les domaines associés
Multiple Sclerosis Research StudiesHeart Failure Treatment and ManagementMigraine and Headache StudiesRetinal Diseases and TreatmentsRetinal and Optic Conditions
Les publications récentes
Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS Registry
Pietro Iaffaldano, Giuseppe Lucisano, Tommaso Guerra, Francesco Patti et autres
it (code pays fourni par la source)
7 citations
Journal of Neurology
HTA237 Cost-Effectiveness Analysis of Ofatumumab for Relapsing Remitting Multiple Sclerosis Treatment in Italy
IC Antonazzo, Mihaela Nica, Paolo Angelo Cortesi, Daniela Ritrovato et autres
it (code pays fourni par la source)
0 citations
Value in Health
PCR13 Economic Advantages Associated With MS DMTs Mode of Administration
it (code pays fourni par la source)
0 citations
Value in Health
The Epidemiology, Treatment Patterns and Economic Burden of Different Phenotypes of Multiple Sclerosis in Italy: Relapsing-Remitting Multiple Sclerosis and Secondary Progressive Multiple Sclerosis
Valentina Perrone, Chiara Veronesi, Elisa Giacomini, Rita Citraro et autres
it (code pays fourni par la source)
14 citations
Clinical Epidemiology
Towards a validated definition of the clinical transition to secondary progressive multiple sclerosis: A study from the Italian MS Register
Pietro Iaffaldano, Giuseppe Lucisano, Tommaso Guerra, Francesco Patti et autres
it (code pays fourni par la source)
11 citations
Multiple Sclerosis Journal
Patients with multiple sclerosis: a burden and cost of illness study
Mario Alberto Battaglia, Daiana Bezzini, Isabella Cecchini, Cinzia Cordioli et autres
it, gb (code pays fourni par la source)
42 citations
Journal of Neurology
Cost-effectiveness and budget impact analysis of siponimod in the treatment of secondary progressive multiple sclerosis in Italy
Paolo Angelo Cortesi, Ippazio Cosimo Antonazzo, Claudio Gasperini, Mihaela Nica et autres
it (code pays fourni par la source)
11 citations
PLoS ONE
POSC400 Epidemiology and Patients' Characteristics in Multiple Sclerosis: An Analysis from the Italian Multiple Sclerosis Registry
Mihaela Nica, Pietro Iaffaldano, María Trojano
it (code pays fourni par la source)
0 citations
Value in Health
POSA155 The Epidemiology and Economic Burden of Different Phenotypes of Multiple Sclerosis (MS) in Italy: Relapsing-Remitting Multiple Sclerosis (RRMS) and Secondary Progressive Multiple Sclerosis (SPMS)
Valentina Perrone, Chiara Veronesi, Elisa Giacomini, Daniela Paoli et autres
it (code pays fourni par la source)
0 citations
Value in Health
Cost-effectiveness and budget impact analysis of siponimod in the treatment of secondary progressive multiple sclerosis in Italy
P. Cortesi, Ippazio Cosimo Antonazzo, Claudio Gasperini, Mihaela Nica et autres
0 citations
DOAJ (DOAJ: Directory of Open Access Journals)
Socioeconomic impact of migraine in Italy: Results of a national survey
Mihaela Nica, Delia Colombo, Roberto Ravasio, Carla Rognoni
it (code pays fourni par la source)
5 citations
AboutOpen
BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.